A multicenter randomized phase II study of the irinotecan/gemcitabine doublet versus irinotecan monotherapy in previously treated patients with extensive stage small-cell lung cancer-Reference-Cited by-同舟云学术

A multicenter randomized phase II study of the irinotecan/gemcitabine doublet versus irinotecan monotherapy in previously treated patients with extensive stage small-cell lung cancer

Published:2009-08 Issue:2 Volume:65 Page:187-191
ISSN:0169-5002
Container-title:Lung Cancer
language:en
Short-container-title:Lung Cancer

Author:

Pallis Athanasios G.,Agelidou Athina,Agelaki Sofia,Varthalitis Ioannis,Pavlakou Georgia,Gerogianni Aleka,Papakotoulas Pavlos,Rapti Ageliki,Chandrinos Vassilis,Christophyllakis Charalampos,Georgoulias Vassilis

Publisher

Elsevier BV

Subject

Cancer Research,Pulmonary and Respiratory Medicine,Oncology

Reference25 articles.

1. Cancer statistics;Jemal;CA Cancer J Clin,2004

2. Small-cell lung cancer;Jackman;Lancet,2005

3. Topotecan versus cyclophosphamide, doxorubicin, and vincristine for the treatment of recurrent small-cell lung cancer;von;J Clin Oncol,1999

4. New drugs for chemotherapy-naive patients with extensive-disease small cell lung cancer;Ettinger;Semin Oncol,2001

5. New chemotherapy agents for small cell lung cancer;Kelly;Chest,2000

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Therapeutic modalities in small cell lung cancer: a paradigm shift after decades of quiescence;Expert Opinion on Pharmacotherapy;2022-02-21

2. Clinical predictors of survival in patients with relapsed/refractory small-cell lung cancer treated with checkpoint inhibitors: a German multicentric real-world analysis;Therapeutic Advances in Medical Oncology;2022-01

3. Tailored-dose chemotherapy with gemcitabine and irinotecan in patients with platinum-refractory/resistant ovarian or primary peritoneal cancer: a phase II trial;Journal of Gynecologic Oncology;2021

4. Comparative effectiveness of nivolumab versus standard of care for third-line patients with small-cell lung cancer;Journal of Comparative Effectiveness Research;2020-12

5. The North American Neuroendocrine Tumor Society Consensus Guidelines for Surveillance and Medical Management of Pancreatic Neuroendocrine Tumors;Pancreas;2020-08